Literature DB >> 17113340

Overexpression of cyclin D1 and cortactin is primarily independent of gene amplification in salivary gland adenoid cystic carcinoma.

Robert O Greer1, Sherif Said, Kenneth R Shroyer, Varella-Garcia Marileila, Scott A Weed.   

Abstract

Adenoid cystic carcinoma (ACC) of the salivary glands exhibits persistent growth, invasion and metastasis. Chromosome 11q13 amplification is a frequent event associated with tumor progression in a number of carcinomas and is associated with poor prognosis. Two genes within the 11q13 amplicon that are overexpressed as a result of 11q13 amplification are the cell cycle regulatory protein cyclin D1 (CCND1) and cortactin (CTTN), a protein involved cell motility and invasion. To determine the expression and gene status of cyclin D1 and cortactin in ACC, we evaluated 39 ACC cases by immunohistochemistry (IHC) for cyclin D1 and cortactin expression. Amplification of CCND1 and CTTN was determined by fluorescent in situ hybridization (FISH). Cyclin D1 overexpression was present in 90% (35/39) and cortactin expression in 62% (24/39) of evaluated cases, although CCND1 and CTTN levels were elevated in only two cases (5%) as determined by FISH. Our results indicate that chromosome 11q13 amplification is uncommon in ACC, but that cyclin D1 and cortactin are frequently overexpressed and may therefore contribute to the growth and invasive potential of ACC.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17113340     DOI: 10.1016/j.oraloncology.2006.09.007

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  13 in total

1.  Expression of cortactin correlates with a poor prognosis in patients with stages II-III colorectal adenocarcinoma.

Authors:  Jian-hua Cai; Ren Zhao; Jian-wei Zhu; Xiao-long Jin; Fang-jun Wan; Kun Liu; Xiao-pin Ji; Yan-bo Zhu; Zheng-gang Zhu
Journal:  J Gastrointest Surg       Date:  2010-06-08       Impact factor: 3.452

Review 2.  Molecular biology of adenoid cystic carcinoma.

Authors:  Jia Liu; Chunbo Shao; Marietta L Tan; David Mu; Robert L Ferris; Patrick K Ha
Journal:  Head Neck       Date:  2011-10-17       Impact factor: 3.147

3.  Dysregulation of the Rb pathway in recurrent pleomorphic adenoma of the salivary glands.

Authors:  Ana Amélia de Souza; Albina Altemani; Fabricio Passador-Santos; Cecilia Pedroso Turssi; Ney Soares de Araujo; Vera Cavalcanti de Araújo; Andresa Borges Soares
Journal:  Virchows Arch       Date:  2015-07-09       Impact factor: 4.064

Review 4.  Cortactin: a multifunctional regulator of cellular invasiveness.

Authors:  Kellye C Kirkbride; Bong Hwan Sung; Seema Sinha; Alissa M Weaver
Journal:  Cell Adh Migr       Date:  2011-03-01       Impact factor: 3.405

5.  The prognostic significance of β-catenin, cyclin D1 and PIN1 in minor salivary gland carcinoma: β-catenin predicts overall survival.

Authors:  Sven Schneider; Dietmar Thurnher; Rudolf Seemann; Markus Brunner; Lorenz Kadletz; Bahil Ghanim; Klaus Aumayr; Gregor Heiduschka; Claudia Lill
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-03-24       Impact factor: 2.503

Review 6.  Cortactin in tumor invasiveness.

Authors:  Alissa M Weaver
Journal:  Cancer Lett       Date:  2008-04-10       Impact factor: 8.679

7.  Cytoskeleton alterations in melanoma: aberrant expression of cortactin, an actin-binding adapter protein, correlates with melanocytic tumor progression.

Authors:  Xu-Zhi Xu; Marileila Varella Garcia; Tian-yu Li; Li-Yan Khor; R Sujatha Gajapathy; Cindy Spittle; Scott Weed; Stuart R Lessin; Hong Wu
Journal:  Mod Pathol       Date:  2009-11-06       Impact factor: 7.842

8.  Cortactin, another player in the Lyn signaling pathway, is over-expressed and alternatively spliced in leukemic cells from patients with B-cell chronic lymphocytic leukemia.

Authors:  Cristina Gattazzo; Veronica Martini; Federica Frezzato; Valentina Trimarco; Elena Tibaldi; Monica Castelli; Monica Facco; Francesca Zonta; Anna Maria Brunati; Renato Zambello; Gianpietro Semenzato; Livio Trentin
Journal:  Haematologica       Date:  2014-02-14       Impact factor: 9.941

9.  Aggressiveness of HNSCC tumors depends on expression levels of cortactin, a gene in the 11q13 amplicon.

Authors:  E S Clark; B Brown; A S Whigham; A Kochaishvili; W G Yarbrough; A M Weaver
Journal:  Oncogene       Date:  2008-10-20       Impact factor: 9.867

10.  Mutation profiling of adenoid cystic carcinomas from multiple anatomical sites identifies mutations in the RAS pathway, but no KIT mutations.

Authors:  Daniel Wetterskog; Paul M Wilkerson; Daniel N Rodrigues; Maryou B Lambros; Karen Fritchie; Mattias K Andersson; Rachael Natrajan; Arnaud Gauthier; Silvana Di Palma; Sami Shousha; Zoran Gatalica; Chantal Töpfer; Vesna Vukovic; Roger A'Hern; Britta Weigelt; Anne Vincent-Salomon; Göran Stenman; Brian P Rubin; Jorge S Reis-Filho
Journal:  Histopathology       Date:  2013-02-12       Impact factor: 5.087

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.